Track topics on Twitter Track topics that are important to you
Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...
Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; prod...
When it comes to hard-to-reach blood clots, endovascular therapy is an effective—and superior—method to medical management, according to a recent study by the University of Texas Health Science Ce...
The first long-term results from the new crop of endovascular trials in stroke show consistent benefit on functional outcomes and suggest a reduction in mortality. Medscape Medical News
Pfizer is planning to terminate its $152 billion merger with Allergan, after the U.S. Treasury Department proposed new tax regulations that would reduce the proposed merger’s advantages, the New Yor...
A 200-patient, multisite clinical trial has been launched by Wayne, Pa.-based Intact Vascular to assess its Tack endovascular -More-
Ebb & Flow Merger mania The unraveling of the merger between Pfizer Inc. (NYSE:PFE) and Allergan plc (NYSE:AGN) has some generalist investors betting bid prices will get more competitive as the two gi...
SAINT HELIER (dpa-AFX) - Baxalta Inc. (BXLT) announced its shareholders approved the definitive merger agreement with Shire plc (SHPG, SHP.L), dated as of January 11, 2016, and the merger transact...
The European Commission has approved under the EU Merger Regulation a proposed merger between IMS Health…
In Reply Dr Elgendy and colleagues suggest that the SYNTHESIS trial should have been excluded from our meta-analysis because the endovascular therapy group did not receive intravenous tPA. At the time...
To evaluate the differences in technical outcomes and secondary interventions between elective endovascular aneurysm repair (el-EVAR) procedures and those for ruptured aneurysms (r-EVAR).
To determine the efficacy of thoracic endovascular aortic repair (TEVAR) for degenerative aneurysm involving only the descending thoracic aorta (DTAA).
To present a new endovascular technique to avoid open surgical arch reconstruction in selected patients with aneurysmal dilatation due to small chronic dissection entries in the aortic arch.
To report midterm outcomes of the Nellix Endovascular Aneurysm Sealing (EVAS) System in the treatment of abdominal aortic aneurysm (AAA).